PMID- 38305614 OWN - NLM STAT- MEDLINE DCOM- 20240205 LR - 20240307 IS - 2284-0729 (Electronic) IS - 1128-3602 (Linking) VI - 28 IP - 2 DP - 2024 Jan TI - Role of alanine aminotransferase in the effects of urinary caffeine concentration and its primary metabolite concentration on cognitive function in older adults: Bayesian Kernel Machine regression analysis and mediation analysis. PG - 721-733 LID - 35072 [pii] LID - 10.26355/eurrev_202401_35072 [doi] AB - OBJECTIVE: This study aimed to explore the role of alanine aminotransferase (ALT) in the effects of urinary caffeine and its primary metabolites on cognitive function in elderly people. MATERIALS AND METHODS: In this investigation, we meticulously curated a cohort from the 2011-2014 National Health and Nutrition Examination Survey (NHANES) database. Animal fluency emerged as the pivotal metric for assessing cognitive function within our study population. In order to navigate the intricacies of mixture analysis and circumvent potential complexities, we harnessed the power of Bayesian kernel machine regression (BKMR) models. This method allowed us to dissect the nuanced impacts of caffeine and its primary urinary metabolites on cognitive function. While accounting for caffeine and its metabolites, we analyzed the relationship between ALT and cognitive function through non-linear dynamics. Lastly, employing structural equation modeling, we probed the intriguing question of whether ALT mediates the influence of 3,7-dimethylxanthine on cognitive function. This comprehensive approach has unveiled a deeper understanding of the multifaceted interplay among these variables, offering invaluable insights into the determinants of cognitive function within our cohort. RESULTS: After meticulous adjustment for various covariates, our linear regression analysis unveiled a noteworthy finding: 3,7-dimethylxanthine demonstrated a significant positive correlation with cognitive function (p < 0.05). Importantly, within the BKMR model employed, 3,7-dimethylxanthine emerged as the most influential factor within the compound, with posterior inclusion probabilities of 0.995 and 0.939. Furthermore, our single-exposure effect model confirmed its presence at the 25th, 50th, and 75th percentile concentrations of other components within the compound. Interestingly, bivariate concentration curves indicated no interaction within the compound, underscoring the prominent impact of 3,7-dimethylxanthine on cognitive function. Subsequently, through a test of Restricted Cubic Splines (RCS), we revealed a non-linear relationship between ALT and cognitive function at the 10th, 50th, and 90th percentiles (p < 0.05), indicating a heightened risk of diminished cognitive function in the low ALT group. Employing structural equation modeling, we meticulously examined the mediating role of ALT in relation to 3,7-dimethylxanthine and cognitive function. However, our study results did not yield significant evidence of a mediating effect. This comprehensive analysis elucidates the intricate interplay between these variables, unveiling the subtle mechanisms governing cognitive function. CONCLUSIONS: In this study, a noteworthy positive correlation was observed between 3,7-dimethylxanthine and cognitive function. Additionally, a non-linear relationship was identified between ALT and cognitive function, with lower levels of ALT associated with a decline in cognitive function. The RCS trend suggested that higher levels of ALT may similarly lead to diminished cognitive performance. However, in our pursuit to ascertain potential mediation, we regrettably found no significant evidence supporting mediation among these factors involving ALT. This underscores the need for more comprehensive investigations and expanded clinical explorations into the intricate associations among these three pivotal elements. FAU - Qin, Y-J AU - Qin YJ AD - Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. 2021120402@stu.cqmu.edu.cn. FAU - Wang, Z-G AU - Wang ZG FAU - Gong, J-H AU - Gong JH FAU - Gong, J-P AU - Gong JP FAU - Li, J-H AU - Li JH LA - eng PT - Journal Article PL - Italy TA - Eur Rev Med Pharmacol Sci JT - European review for medical and pharmacological sciences JID - 9717360 RN - EC 2.6.1.2 (Alanine Transaminase) RN - 3G6A5W338E (Caffeine) SB - IM MH - Aged MH - Humans MH - *Alanine Transaminase/metabolism MH - Bayes Theorem MH - *Caffeine/urine MH - *Cognition MH - Mediation Analysis MH - Nutrition Surveys EDAT- 2024/02/02 12:44 MHDA- 2024/02/05 06:43 CRDT- 2024/02/02 09:39 PHST- 2024/02/05 06:43 [medline] PHST- 2024/02/02 12:44 [pubmed] PHST- 2024/02/02 09:39 [entrez] AID - 35072 [pii] AID - 10.26355/eurrev_202401_35072 [doi] PST - ppublish SO - Eur Rev Med Pharmacol Sci. 2024 Jan;28(2):721-733. doi: 10.26355/eurrev_202401_35072.